ENTBF
Price
$0.07
Change
-$0.00 (-0.00%)
Updated
Jul 2 closing price
Capitalization
1.02M
SER
Price
$5.94
Change
-$0.20 (-3.26%)
Updated
Jul 3 closing price
Capitalization
59.21M
Interact to see
Advertisement

ENTBF vs SER

Header iconENTBF vs SER Comparison
Open Charts ENTBF vs SERBanner chart's image
ENTHEON BIOMEDICAL
Price$0.07
Change-$0.00 (-0.00%)
Volume$1.09K
Capitalization1.02M
Serina Therapeutics
Price$5.94
Change-$0.20 (-3.26%)
Volume$1.15K
Capitalization59.21M
ENTBF vs SER Comparison Chart in %
Loading...
ENTBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SER
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ENTBF vs. SER commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ENTBF is a Hold and SER is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 07, 2025
Stock price -- (ENTBF: $0.07 vs. SER: $5.94)
Brand notoriety: ENTBF and SER are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ENTBF: 63% vs. SER: 9%
Market capitalization -- ENTBF: $1.02M vs. SER: $59.21M
ENTBF [@Biotechnology] is valued at $1.02M. SER’s [@Biotechnology] market capitalization is $59.21M. The market cap for tickers in the [@Biotechnology] industry ranges from $316.35B to $0. The average market capitalization across the [@Biotechnology] industry is $2.39B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ENTBF’s FA Score shows that 0 FA rating(s) are green whileSER’s FA Score has 0 green FA rating(s).

  • ENTBF’s FA Score: 0 green, 5 red.
  • SER’s FA Score: 0 green, 5 red.
According to our system of comparison, ENTBF is a better buy in the long-term than SER.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ENTBF’s TA Score shows that 1 TA indicator(s) are bullish while SER’s TA Score has 7 bullish TA indicator(s).

  • ENTBF’s TA Score: 1 bullish, 7 bearish.
  • SER’s TA Score: 7 bullish, 1 bearish.
According to our system of comparison, SER is a better buy in the short-term than ENTBF.

Price Growth

ENTBF (@Biotechnology) experienced а +0.37% price change this week, while SER (@Biotechnology) price change was -3.10% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.30%. For the same industry, the average monthly price growth was +17.40%, and the average quarterly price growth was -0.11%.

Industries' Descriptions

@Biotechnology (+6.30% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SER($59.2M) has a higher market cap than ENTBF($1.02M). SER YTD gains are higher at: 18.563 vs. ENTBF (-50.313). ENTBF has higher annual earnings (EBITDA): -403.94K vs. SER (-488K). SER has more cash in the bank: 4.27M vs. ENTBF (525K). ENTBF (0) and SER (0) have equivalent revenues.
ENTBFSERENTBF / SER
Capitalization1.02M59.2M2%
EBITDA-403.94K-488K83%
Gain YTD-50.31318.563-271%
P/E RatioN/A1.76-
Revenue00-
Total Cash525K4.27M12%
Total DebtN/A227K-
FUNDAMENTALS RATINGS
SER: Fundamental Ratings
SER
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
83
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
55
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ENTBFSER
RSI
ODDS (%)
Bearish Trend 5 days ago
83%
N/A
Stochastic
ODDS (%)
Bullish Trend 5 days ago
76%
Bearish Trend 5 days ago
90%
Momentum
ODDS (%)
Bearish Trend 5 days ago
89%
Bullish Trend 5 days ago
82%
MACD
ODDS (%)
Bearish Trend 5 days ago
89%
Bullish Trend 5 days ago
88%
TrendWeek
ODDS (%)
Bullish Trend 5 days ago
84%
Bearish Trend 5 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 5 days ago
84%
Bullish Trend 5 days ago
83%
Advances
ODDS (%)
N/A
Bullish Trend 11 days ago
81%
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
Bearish Trend 5 days ago
90%
Bullish Trend 5 days ago
81%
Aroon
ODDS (%)
Bearish Trend 5 days ago
90%
Bullish Trend 5 days ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
ENTBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SER
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SSPPF2.15N/A
N/A
SSP Group PLC
MBLU21.99N/A
N/A
Morris State Bancshares, Inc.
CCOEF31.95N/A
N/A
Capcom Co. Ltd
BRQSF0.15N/A
-0.10%
Borqs Technologies, Inc.
BLAGF0.54-0.01
-1.35%
Blue Lagoon Resources Inc.

ENTBF and

Correlation & Price change

A.I.dvisor indicates that over the last year, ENTBF has been loosely correlated with SER. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if ENTBF jumps, then SER could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ENTBF
1D Price
Change %
ENTBF100%
N/A
SER - ENTBF
35%
Loosely correlated
-3.26%
IMRX - ENTBF
31%
Poorly correlated
-3.90%
XTLB - ENTBF
29%
Poorly correlated
+10.00%
GERN - ENTBF
27%
Poorly correlated
+2.14%
LABFF - ENTBF
20%
Poorly correlated
N/A
More

SER and

Correlation & Price change

A.I.dvisor indicates that over the last year, SER has been loosely correlated with GERN. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if SER jumps, then GERN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SER
1D Price
Change %
SER100%
-3.26%
GERN - SER
65%
Loosely correlated
+2.14%
XTLB - SER
59%
Loosely correlated
+10.00%
ELVN - SER
37%
Loosely correlated
+0.44%
ENTBF - SER
35%
Loosely correlated
N/A
TOVX - SER
34%
Loosely correlated
-1.56%
More